Literature DB >> 6252832

In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.

J H Jorgensen, S A Crawford, G A Alexander.   

Abstract

The in vitro activities of two new beta-lactam antibiotics, cefotaxime and moxalactam (LY127935), were compared with those of cefamandole, cefoxitin, cefuroxime, and ampicillin against both beta-lactamase-producing and non-beta-lactamase-producing isolates of Haemophilus influenzae. Both cefotaxime and LY127935 were highly active against all isolates irrespective of beta-lactamase production.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252832      PMCID： PMC283820          DOI： 10.1128/AAC.17.3.516

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Prevalence of ampicillin- and chloramphenicol-resistant strains of Haemophilus influenzae causing meningitis and bacteremia: national survey of hospital laboratories.

Authors:  J I Ward; T F Tsai; G A Filice; D W Fraser
Journal:  J Infect Dis       Date:  1978-09       Impact factor: 5.226

2.  Ampicillin-resistant Haemophilus influenzae type B infection.

Authors:  M O Tomeh; S E Starr; J E McGowan; P M Terry; A J Nahmias
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

3.  Haemophilus influenzae type B resistant to ampicillin. A report of two cases.

Authors:  W Khan; S Ross; W Rodriguez; G Controni; A K Saz
Journal:  JAMA       Date:  1974-07-15       Impact factor: 56.272

4.  Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae.

Authors:  J H Jorgensen; G A Alexander
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

5.  Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae.

Authors:  J H Jorgensen; J C Lee; G A Alexander
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

6.  Chloramphenicol resistance in Haemophilus influenzae.

Authors:  A Manten; B van Klingeren; M Dessens-Kroon
Journal:  Lancet       Date:  1976-03-27       Impact factor: 79.321

7.  Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens.

Authors:  J J Rahal; M S Simberkoff
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

8.  HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin.

Authors:  R Wise; T Rollason; M Logan; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

9.  Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.

Authors:  J P Sosna; P R Murray; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

10.  In vitro of cefotaxime against cephalothin-resistant clinical isolates.

Authors:  H W Van Landuyt; M Pyckavet
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191
  10 in total
  4 in total

1.  [Rational parameters in the treatment of bacterial meningitis with modern cephalosporins].

Authors:  O Brückner; M Trautmann
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 2.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

Review 3.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

4.  Moxalactam pharmacokinetics in children.

Authors:  M F Romagnoli; K Flynn; G R Siber; D A Goldmann
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.